Keywords: crestor, better, lipitor, hispanics, anglo-swedish, drug, major
Crestor better than Lipitor in Hispanics
Article | 03 April 2006
Anglo-Swedish drug major AstraZeneca says that Crestor (rosuvastatin) reduced low-density lipoprotein cholesterol more than milligram-equivalent doses of Pfizer's Lipitor (atorvastatin) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
